South America Point of Care Diagnostics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Glucose Monitoring Products, Infectious Disease Testing Products, Cardiometabolic Testing Products, Pregnancy and Fertility Testing Products, Coagulation Testing Products, Tumor/Cancer Marker Testing Products, Cholesterol Testing Products, Urinalysis Testing Products, Hematology Testing Products, and Other POC Products), Prescription Mode (Prescription-Based Testing and OTC Testing), and End User (Professional Diagnostic Centers, Home Care, Research Laboratories, and Others)

No. of Pages: 174    |    Report Code: TIPRE00023725    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South America Point of Care Diagnostics Market

TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        SAM Point of Care Diagnostics Market – By Product

1.3.2        SAM Point of Care Diagnostics Market – By Prescription Mode

1.3.3        SAM Point of Care Diagnostics Market – By End User

1.3.4        SAM Point of Care Diagnostics Market – By Country

2.           Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           SAM Point of Care Diagnostics Market – Market Landscape

4.1         Overview

4.2         SAM PEST Analysis

5.           SAM Point of Care Diagnostics Market – Key Industry Dynamics

5.1         Key Market Drivers

5.1.1        Increasing Prevalence of Infectious Diseases

5.1.2        Product Launches and Product Developments

5.1.3        Increasing Number of CLIA-waived POC tests

5.2         Market Restraints

5.2.1        Product Recalls in Market

5.3         Market Opportunities

5.3.1        Burgeoning Number of Conferences and Events

5.4         Future Trends

5.4.1        Accelerating Use of Home-Based POC Devices

5.5         Impact Analysis

6.           Point of Care Diagnostics Market – SAM Analysis

6.1         SAM Point of Care Diagnostics Market Revenue Forecast and Analysis

7.           SAM Point of Care Diagnostics Market Analysis– by Product

7.1         Overview

7.2         SAM Point of Care Diagnostics Market, By Product 2020 & 2028 (%)

7.3         Glucose Monitoring

7.3.1        Overview

7.3.2        Glucose Monitoring Market Revenue and Forecasts to 2028 (US$ Mn)

7.4         Infectious Disease Testing

7.4.1        Overview

7.4.2        Infectious Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.3        HIV Testing

7.4.3.1          Overview

7.4.3.2          HIV Testing Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.4        Influenza Testing

7.4.4.1          Overview

7.4.4.2          Influenza Testing Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.5        Sexually Transmitted Disease (STD) Testing

7.4.5.1          Overview

7.4.5.2          Sexually Transmitted Disease (STD) Testing Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.6        Hepatitis C Testing

7.4.6.1          Overview

7.4.6.2          Hepatitis C Testing Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.7        Healthcare-Associated Infection (HAI) Testing

7.4.7.1          Overview

7.4.7.2          Healthcare-Associated Infection (HAI) Testing Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.8        Tropical Disease Testing

7.4.8.1          Overview

7.4.8.2          Tropical Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.9        Respiratory Infection Testing

7.4.9.1          Overview

7.4.9.2          Respiratory Infection Testing Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.10     Other Infectious Disease

7.4.10.1       Overview

7.4.10.2       Others Infection Disease Market Revenue and Forecasts to 2028 (US$ Mn)

7.5         Cardiometabolic Testing

7.5.1        Overview

7.5.2        Cardiometabolic Testing Market Revenue and Forecasts to 2028 (US$ Mn)

7.6         Pregnancy and Fertility Testing

7.6.1        Overview

7.6.2        Pregnancy and Fertility Testing Market Revenue and Forecasts to 2028 (US$ Mn)

7.7         Coagulation Testing

7.7.1        Overview

7.7.2        Coagulation Testing Market Revenue and Forecasts to 2028 (US$ Mn)

7.8         Tumor/Cancer Marker Testing

7.8.1        Overview

7.8.2        Tumor/Cancer Marker Testing Market Revenue and Forecasts to 2028 (US$ Mn)

7.9         Cholesterol Testing

7.9.1        Overview

7.9.2        Cholesterol Testing Market Revenue and Forecasts to 2028 (US$ Mn)

7.10      Urinalysis Testing

7.10.1     Overview

7.10.2     Urinalysis Testing Market Revenue and Forecasts to 2028 (US$ Mn)

7.11      Haematology Testing

7.11.1     Overview

7.11.2     Haematology Testing Revenue and Forecasts to 2028 (US$ Mn)

7.12      Other POC

7.12.1     Overview

7.12.2     Other POC Market Revenue and Forecasts to 2028 (US$ Mn)

8.           SAM Point of Care Diagnostics Market Analysis– by Prescription Mode

8.1         Overview

8.2         SAM Point of Care Diagnostics Market, By Prescription Mode 2020 & 2028 (%)

8.3         Prescription-Based Testing Market

8.3.1        Overview

8.3.2        Prescription-Based Testing Market Revenue and Forecasts to 2028 (US$ Mn)

8.4         OTC Testing Market

8.4.1        Overview

8.4.2        OTC Testing Market Revenue and Forecasts to 2028 (US$ Mn)

9.           SAM Point of Care Diagnostics Market Analysis– by End User

9.1         Overview

9.2         SAM Point of Care Diagnostics Market, By End User 2020 & 2028 (%)

9.3         Professional Diagnostic Centers

9.3.1        Overview

9.3.2        Professional Diagnostic Centers Market Revenue and Forecasts to 2028 (US$ Mn)

9.3.3        Hospitals

9.3.3.1          Overview

9.3.3.2          Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)

9.3.4        Clinical Laboratories

9.3.4.1          Overview

9.3.4.2          Clinical Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)

9.3.5        Outpatient Healthcare

9.3.5.1          Overview

9.3.5.2          Outpatient Healthcare Market Revenue and Forecasts to 2028 (US$ Mn)

9.3.6        Ambulatory Care Settings

9.3.6.1          Overview

9.3.6.2          Ambulatory Care Settings Market Revenue and Forecasts to 2028 (US$ Mn)

9.4         Home Care

9.4.1        Overview

9.4.2        Home Care Market Revenue and Forecasts to 2028 (US$ Mn)

9.5         Research Laboratories

9.5.1        Overview

9.5.2        Research Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)

9.6         Others

9.6.1        Overview

9.6.2        Others Market Revenue and Forecasts to 2028 (US$ Mn)

10.        SAM Point of Care Diagnostics Market – Country Analysis

10.1      SAM: Point of Care Diagnostics Market

10.1.1     Overview

10.1.2     SAM: Point of Care Diagnostics Market, By Country, 2020 & 2028 (%)

10.1.3     Argentina: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

10.1.3.1       Argentina: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

10.1.3.2       Argentina: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)

10.1.3.2.1       Argentina: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)

10.1.3.3       Argentina: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)

10.1.3.4       Argentina: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)

10.1.3.4.1       Argentina: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)

10.1.4     Brazil: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

10.1.4.1       Brazil: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

10.1.4.2       Brazil: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)

10.1.4.2.1       Brazil: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)

10.1.4.3       Brazil: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)

10.1.4.4       Brazil: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)

10.1.4.4.1       Brazil: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)

10.1.5     Rest of SAM: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

10.1.5.1       Rest of SAM: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

10.1.5.2       Rest of SAM: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)

10.1.5.2.1       Rest of SAM: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)

10.1.5.3       Rest of SAM: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)

10.1.5.4       Rest of SAM: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)

10.1.5.4.1       Rest of SAM: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)

11.        Impact of COVID-19 Pandemic on SAM Point of Care Diagnostics Market

11.1      SAM: Impact Assessment of COVID-19 Pandemic

12.        Industry Landscape

12.1      Overview

12.2      Organic Growth Strategies

12.2.1     Overview

12.3      Inorganic Growth Strategies

12.3.1     Overview

13.        Company Profiles

13.1      F. HOFFMANN-LA ROCHE LTD.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Danaher

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      BIO-RAD LABORATORIES INC.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Abbott

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Johnson and Johnson Services, Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Siemens AG

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      BD

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      bioMerieux SA

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4

13.8.5     Financial Overview

13.8.6     SWOT Analysis

13.8.7     Key Developments

13.9      Polymer Technology Systems, Inc. (PTS)

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Nova Biomedical

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About the Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             SAM Point of Care Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Argentina: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)

Table 3.             Argentina: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)

Table 4.             Argentina: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)

Table 5.             Argentina: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)

Table 6.             Argentina: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)

Table 7.             Brazil: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)

Table 8.             Brazil: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)

Table 9.             Brazil: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)

Table 10.          Brazil: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)

Table 11.          Brazil: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)

Table 12.          Rest of SAM: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)

Table 13.          Rest of SAM: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)

Table 14.          Rest of SAM: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)

Table 15.          Rest of SAM: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)

Table 16.          Rest of SAM: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)

Table 17.          Recent Organic Developments the Point of Care Diagnostics Market

Table 18.          Recent Inorganic Developments in the Point of Care Diagnostics Market

Table 19.          Glossary of Terms

LIST OF FIGURES

Figure 1.           SAM Point of Care Diagnostics Market Segmentation

Figure 2.           SAM Point of Care Diagnostics Market Segmentation, By Country

Figure 3.           SAM Point of Care Diagnostics Market Overview

Figure 4.           Prescription-Based Testing Segment Held Largest Share of SAM Point of Care Diagnostics Market

Figure 5.           Brazil to Show Significant Growth During Forecast Period

Figure 6.           SAM: PEST Analysis

Figure 7.           Impact Analysis of Driver and Restraints Pertaining to SAM Point of Care Diagnostics Market

Figure 8.           SAM Point of Care Diagnostics Market – Revenue Forecast and Analysis

Figure 9.           SAM Point of Care Diagnostics Market, by Products 2020 & 2028 (%)

Figure 10.        SAM Glucose Monitoring Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11.        SAM Infectious Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12.        SAM HIV Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13.        SAM Influenza Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14.        SAM Sexually Transmitted Disease (STD) Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15.        SAM Hepatitis C Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 16.        SAM Healthcare-Associated Infection (HAI) Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17.        SAM Tropical Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18.        SAM Respiratory Infection Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19.        SAM Others Infection Disease Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20.        SAM Cardiometabolic Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21.        SAM Pregnancy and Fertility Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22.        SAM Coagulation Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23.        SAM Tumor/Cancer Marker Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24.        SAM Cholesterol Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25.        SAM Urinalysis Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26.        SAM Haematology Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27.        SAM Other POC Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28.        SAM Point of Care Diagnostics Market, by Prescription Mode 2020 & 2028 (%)

Figure 29.        SAM Prescription-Based Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 30.        SAM OTC Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 31.        SAM Point of Care Diagnostics Market, by End User 2020 & 2028 (%)

Figure 32.        SAM Professional Diagnostic Centers Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 33.        SAM Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 34.        SAM Clinical Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 35.        SAM Outpatient Healthcare Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 36.        SAM Ambulatory Care Settings Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 37.        SAM Home Care Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 38.        SAM Research Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 39.        SAM Others Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 40.        SAM: Point of Care Diagnostics Market, by Key Country- Revenue (2020) (USD Million)

Figure 41.        SAM: Point of Care Diagnostics Market, By Country, 2020 & 2028 (%)

Figure 42.        Argentina: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

Figure 43.        Brazil: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

Figure 44.        Rest of SAM: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

Figure 45.        Impact of COVID-19 Pandemic in SAM Country Markets

The List of Companies - South America Point of Care Diagnostics Market

  1. Abbott
  2. BD
  3. bioMerieux SA
  4. BIO-RAD LABORATORIES INC.
  5. Danaher
  6. F. HOFFMANN-LA ROCHE LTD.
  7. Johnson and Johnson Services, Inc. 
  8. Nova Biomedical
  9. Polymer Technology Systems, Inc. (PTS)
  10. Siemens AG